The menopause has moved on from simply being a source of euphemisms for hot flushes as ‘power surges’ or ‘tropical moments’ to being recognised as an important stage in a woman’s life. It also has particular significance in CVD risk, which we address head-on in this issue of BJPCN.
Starting on a statin for primary prevention
Tredaptive: a new option in lipid management
Blood cholesterol levels play an important role in the development of atherosclerosis and cardiovascular disease (CVD), and the incidence of CVD is closely related to the concentration of the specific lipoproteins in the blood. In this article, we review the role of different lipoproteins and the mechanism of action and potential role of a new agent for lipid modification – Tredaptive.
How to prevent and manage lipohypertrophy at injection sites
Lipohypertrophy is surprisingly common in people using insulin to control their diabetes. As more and more people with diabetes are managed in primary care, practice nurses take on a greater role in the management and education of these patients. This article considers what lipohypertrophy is, how it can be prevented and how it should be managed once it has been identified.
